Atorvastatin blev givet i doser op til 80 mg/ døgn i et ukontrolleret klinisk studie med 64 patienter, heraf 46 med påvist homozygot familiær hyperkolesterolæmi.
In a compassionate-use study of 64 patients there were 46 patients for whom confirmed LDL receptor information was available.